Checking In on Pacific Biosciences to See If It's Still a Good 'Idea'
Let's review the charts of PACB again.
Does Silk Road Medical Have a Smooth Path Forward?
After gaining a fundamental supporter, here's how aggressive traders could play the stock.
Medtronic Could Touch a New Low as It Bottoms
Let's see what the the charts and indicators look like.
Gilead Sciences Could Retreat Further From Here
Share prices peaked in December.
Boston Scientific's Wicked Rally Can Take the Stock 20% Higher
BSX has rallied the past nine months.
Why Weakness in Sarepta Therapeutics Is Likely to Continue
The trading days between the gaps look like an island surrounded by water.
When Will AbbVie's Long-Term Trend Reassert Itself?
Let's drill down on the charts.
3 High Dividend Healthcare Stocks for Passive Income
These recession-resilient names offer above-average dividend yields and decent growth prospects.
Here's How Innovation Can Drive Apple Higher
The tech giant's stock won a buy rating from Goldman Sachs, and its work on a medical innovation could be a game-changer.
As Covid Threat Weakens, This Biotech Is Still Worth a Shot
Here's a way to trade Vir Biotechnology.